MA38973B1 - Aminoheteroaryl benzamides as kinase inhibitors - Google Patents

Aminoheteroaryl benzamides as kinase inhibitors

Info

Publication number
MA38973B1
MA38973B1 MA38973A MA38973A MA38973B1 MA 38973 B1 MA38973 B1 MA 38973B1 MA 38973 A MA38973 A MA 38973A MA 38973 A MA38973 A MA 38973A MA 38973 B1 MA38973 B1 MA 38973B1
Authority
MA
Morocco
Prior art keywords
aminoheteroaryl
benzamides
kinase inhibitors
compounds
present
Prior art date
Application number
MA38973A
Other languages
French (fr)
Other versions
MA38973A1 (en
Inventor
Keith Bruce Pfister
Yue Pan
Jeffrey T Bagdanoff
Yu Ding
Wooseok Han
Zilin Huang
Qun Jiang
Jeff Xianming Jin
Xiang Kou
Patrick Lee
Mika Lindvall
Zhongcheng Min
Sabina Pecchi
Daniel Poon
Vivek Rauniyar
Xiaojing Michael Wang
Qiong Zhang
Jianguang Zhou
Shejin Zhu
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from PCT/US2014/062913 external-priority patent/WO2015066188A1/en
Publication of MA38973A1 publication Critical patent/MA38973A1/en
Publication of MA38973B1 publication Critical patent/MA38973B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne un composé de formule (i) ou un sel de celui-ci, et des utilisations thérapeutiques de ces composés. La présente invention concerne en outre des compositions pharmaceutiques comprenant ces composés, et des compositions comprenant ces composés avec un co-agent thérapeutique.The present invention relates to a compound of formula (i) or a salt thereof, and therapeutic uses thereof. The present invention further relates to pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a co-therapeutic agent.

MA38973A 2014-10-11 2014-10-29 Aminoheteroaryl benzamides as kinase inhibitors MA38973B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2014088409 2014-10-11
PCT/US2014/062913 WO2015066188A1 (en) 2013-11-01 2014-10-29 Aminoheteroaryl benzamides as kinase inhibitors

Publications (2)

Publication Number Publication Date
MA38973A1 MA38973A1 (en) 2018-06-29
MA38973B1 true MA38973B1 (en) 2018-10-31

Family

ID=63586950

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38973A MA38973B1 (en) 2014-10-11 2014-10-29 Aminoheteroaryl benzamides as kinase inhibitors

Country Status (1)

Country Link
MA (1) MA38973B1 (en)

Also Published As

Publication number Publication date
MA38973A1 (en) 2018-06-29

Similar Documents

Publication Publication Date Title
PH12019550050A1 (en) Isoxazole analogs as fxr agonists and methods of use thereof
PH12018502535B1 (en) Substituted carbonucleoside derivatives useful as anticancer agents
PH12017501413A1 (en) Substituted nucleoside derivatives useful as anticancer agents
PH12016502382A1 (en) Substituted indazole compounds as irak4 inhibitors
JO3452B1 (en) Aminoheteroaryl benzamides as kinase inhibitors
GEP20207105B (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors
PH12016501966A1 (en) Compounds and compositions as toll-like receptor 7 agonists
MA38398A1 (en) Biaryl amide compounds as kinase inhibitors
MY197698A (en) Oxysterols and methods of use thereof
TN2017000075A1 (en) Compounds and compositions as raf kinase inhibitors
EA201990279A1 (en) HERBICIDAL COMPOSITIONS CONTAINING PHENYLPYRIMIDINES
MA39983B1 (en) Carboxamide derivatives
MA39152A1 (en) 1,2-substituted cyclopentanes used as orexin receptor antagonists
MX2022000945A (en) Composition for increasing expression of pgc-1î±.
MA38884A1 (en) Triazolopyridine compound, compositions and methods of use thereof
MX2018008307A (en) Ascochlorin derivative and use thereof as ampk activator.
MX2017006709A (en) Agent for preventing or improving symptoms caused by imbalance of sex hormones.
MA38358A1 (en) Formulations of organic compounds
MA39305A3 (en) Ethynyl derivatives
NZ738247A (en) 4-(3-pyrazolylamino)-benzimidazole compounds and their use as jak1 inhibitors
MA38973B1 (en) Aminoheteroaryl benzamides as kinase inhibitors
WO2015181837A3 (en) Novel compounds as anti-tubercular agents
MX2016011310A (en) Endoparasite control agent.
MX2016011308A (en) Endoparasite control agent.
FR3022245B1 (en) 3,5-DIHYDRO-2H-PYRAZOLO [4,3-C] PYRIDIN-3-ONE DERIVATIVES AND THEIR USE